NCT02715609 Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT02709226 Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT02704858 Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma Status RECRUITING Phase PHASE1/PHASE2
NCT02663440 Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme Status UNKNOWN Phase PHASE2
NCT02663271 TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma Status TERMINATED Phase PHASE2
NCT02619864 mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02590263 Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT02586857 A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02546102 Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma Status SUSPENDED Phase PHASE3
NCT02540135 Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma Status WITHDRAWN Phase NA
NCT02510950 Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma Status TERMINATED Phase PHASE1
NCT02507102 A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia Status COMPLETED Phase NA
NCT02502708 Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors Status COMPLETED Phase PHASE1
NCT02498665 A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02465268 Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT02414165 The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma Status TERMINATED Phase PHASE2/PHASE3
NCT02386826 INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE1